{"id":4924,"date":"2025-07-09T15:28:58","date_gmt":"2025-07-09T19:28:58","guid":{"rendered":"https:\/\/med.virginia.edu\/bims\/?p=4924"},"modified":"2026-05-01T15:12:30","modified_gmt":"2026-05-01T19:12:30","slug":"andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy","status":"publish","type":"post","link":"https:\/\/med.virginia.edu\/bims\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\/","title":{"rendered":"Andrew Dudley, PhD, Earns $2.7 Million NIH Grant to Alleviate Toxicities Associated With Immunotherapy"},"content":{"rendered":"<div id=\"attachment_48399\" class=\"wp-caption alignright\">\n<p><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-48399\" src=\"https:\/\/news.med.virginia.edu\/files\/2025\/06\/Dudley_Andrew-1x1-1-300x300.jpg\" alt=\"Andrew Dudley, PhD\" width=\"350\" height=\"350\" aria-describedby=\"caption-attachment-48399\" \/><\/p>\n<p id=\"caption-attachment-48399\" class=\"wp-caption-text\">Andrew Dudley, PhD<\/p>\n<\/div>\n<p>Andrew Dudley, PhD, a professor in the Department of Microbiology, Immunology, and Cancer Biology, has been awarded a $2.7 million NIH grant for a project titled \u201cTargeting the vasculature to enhance anti-tumor immunity.\u201d This renewal award extends the project\u2019s continuous funding into its 16th year.<\/p>\n<p>Tumor blood vessels facilitate the entry of anti-tumor immune cells into the tumor microenvironment. However, abnormalities in these vessels can hinder immune cell access, leading to inadequate responses to cancer immunotherapy. Surprisingly, the Dudley lab discovered that targeting the epigenetic gene silencer DNA methyltransferase 1 (Dnmt1) can modify tumor-associated blood vessels in a manner that enhances immunotherapy responses. This suggests that epigenetic reprogramming of the tumor vasculature could ultimately improve the efficacy of immunotherapy and bolster tumor immune surveillance.<\/p>\n<p>Dr. Dudley\u2019s project aims to inform the development of vascular-directed approaches that can enhance the effectiveness of cancer immunotherapies or reduce the required dose of immunotherapy for a favorable and sustained response. This approach could potentially alleviate the toxicities associated with immunotherapy in patients fighting cancer.<\/p>\n<p>Collaborators on the project include Melanie Rutkowski, PhD, and Craig Slingluff, MD, both at UVA.<\/p>\n<p>Originally posted in UVA Medicine in Motion News on <strong>July 1, 2025 by\u00a0<a href=\"https:\/\/news.med.virginia.edu\/author\/daf4avirginia-edu\/\">daf4a@virginia.edu<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Andrew Dudley, PhD Andrew Dudley, PhD, a professor in the Department of Microbiology, Immunology, and Cancer Biology, has been awarded a $2.7 million NIH grant for a project titled \u201cTargeting the vasculature to enhance anti-tumor immunity.\u201d This renewal award extends the project\u2019s continuous funding into its 16th year. Tumor blood vessels facilitate the entry of [&hellip;]<\/p>\n","protected":false},"author":2214,"featured_media":4926,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[4],"tags":[],"class_list":["post-4924","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-research-highlights"],"acf":false,"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Andrew Dudley, PhD, Earns $2.7 Million NIH Grant to Alleviate Toxicities Associated With Immunotherapy - Biomedical Sciences Graduate Program<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/med.virginia.edu\/bims\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Andrew Dudley, PhD, Earns $2.7 Million NIH Grant to Alleviate Toxicities Associated With Immunotherapy - Biomedical Sciences Graduate Program\" \/>\n<meta property=\"og:description\" content=\"Andrew Dudley, PhD Andrew Dudley, PhD, a professor in the Department of Microbiology, Immunology, and Cancer Biology, has been awarded a $2.7 million NIH grant for a project titled \u201cTargeting the vasculature to enhance anti-tumor immunity.\u201d This renewal award extends the project\u2019s continuous funding into its 16th year. Tumor blood vessels facilitate the entry of [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/med.virginia.edu\/bims\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\/\" \/>\n<meta property=\"og:site_name\" content=\"Biomedical Sciences Graduate Program\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-09T19:28:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-01T19:12:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/med.virginia.edu\/bims\/wp-content\/uploads\/sites\/390\/2025\/07\/Dudley_Andrew-1x1-1-300x300-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"300\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"amc3yu@virginia.edu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"amc3yu@virginia.edu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\\\/\"},\"author\":{\"name\":\"amc3yu@virginia.edu\",\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/#\\\/schema\\\/person\\\/04dfd1e9dffba7133a63ffcb935dbad5\"},\"headline\":\"Andrew Dudley, PhD, Earns $2.7 Million NIH Grant to Alleviate Toxicities Associated With Immunotherapy\",\"datePublished\":\"2025-07-09T19:28:58+00:00\",\"dateModified\":\"2026-05-01T19:12:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\\\/\"},\"wordCount\":216,\"image\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/wp-content\\\/uploads\\\/sites\\\/390\\\/2025\\\/07\\\/Dudley_Andrew-1x1-1-300x300-1.webp\",\"articleSection\":[\"Research Highlights\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\\\/\",\"url\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\\\/\",\"name\":\"Andrew Dudley, PhD, Earns $2.7 Million NIH Grant to Alleviate Toxicities Associated With Immunotherapy - Biomedical Sciences Graduate Program\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/wp-content\\\/uploads\\\/sites\\\/390\\\/2025\\\/07\\\/Dudley_Andrew-1x1-1-300x300-1.webp\",\"datePublished\":\"2025-07-09T19:28:58+00:00\",\"dateModified\":\"2026-05-01T19:12:30+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/#\\\/schema\\\/person\\\/04dfd1e9dffba7133a63ffcb935dbad5\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/wp-content\\\/uploads\\\/sites\\\/390\\\/2025\\\/07\\\/Dudley_Andrew-1x1-1-300x300-1.webp\",\"contentUrl\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/wp-content\\\/uploads\\\/sites\\\/390\\\/2025\\\/07\\\/Dudley_Andrew-1x1-1-300x300-1.webp\",\"width\":300,\"height\":300,\"caption\":\"Andrew Dudley PhD\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Andrew Dudley, PhD, Earns $2.7 Million NIH Grant to Alleviate Toxicities Associated With Immunotherapy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/#website\",\"url\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/\",\"name\":\"Biomedical Sciences Graduate Program\",\"description\":\"University of Virginia School of Medicine\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/#\\\/schema\\\/person\\\/04dfd1e9dffba7133a63ffcb935dbad5\",\"name\":\"amc3yu@virginia.edu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/14b7fd4ac1415b0f4430fd13352b7565baec1c8cde504b3154183d83d9c35a25?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/14b7fd4ac1415b0f4430fd13352b7565baec1c8cde504b3154183d83d9c35a25?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/14b7fd4ac1415b0f4430fd13352b7565baec1c8cde504b3154183d83d9c35a25?s=96&d=mm&r=g\",\"caption\":\"amc3yu@virginia.edu\"},\"url\":\"https:\\\/\\\/med.virginia.edu\\\/bims\\\/author\\\/amc3yuvirginia-edu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Andrew Dudley, PhD, Earns $2.7 Million NIH Grant to Alleviate Toxicities Associated With Immunotherapy - Biomedical Sciences Graduate Program","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/med.virginia.edu\/bims\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\/","og_locale":"en_US","og_type":"article","og_title":"Andrew Dudley, PhD, Earns $2.7 Million NIH Grant to Alleviate Toxicities Associated With Immunotherapy - Biomedical Sciences Graduate Program","og_description":"Andrew Dudley, PhD Andrew Dudley, PhD, a professor in the Department of Microbiology, Immunology, and Cancer Biology, has been awarded a $2.7 million NIH grant for a project titled \u201cTargeting the vasculature to enhance anti-tumor immunity.\u201d This renewal award extends the project\u2019s continuous funding into its 16th year. Tumor blood vessels facilitate the entry of [&hellip;]","og_url":"https:\/\/med.virginia.edu\/bims\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\/","og_site_name":"Biomedical Sciences Graduate Program","article_published_time":"2025-07-09T19:28:58+00:00","article_modified_time":"2026-05-01T19:12:30+00:00","og_image":[{"width":300,"height":300,"url":"https:\/\/med.virginia.edu\/bims\/wp-content\/uploads\/sites\/390\/2025\/07\/Dudley_Andrew-1x1-1-300x300-1.webp","type":"image\/webp"}],"author":"amc3yu@virginia.edu","twitter_card":"summary_large_image","twitter_misc":{"Written by":"amc3yu@virginia.edu","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/med.virginia.edu\/bims\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\/#article","isPartOf":{"@id":"https:\/\/med.virginia.edu\/bims\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\/"},"author":{"name":"amc3yu@virginia.edu","@id":"https:\/\/med.virginia.edu\/bims\/#\/schema\/person\/04dfd1e9dffba7133a63ffcb935dbad5"},"headline":"Andrew Dudley, PhD, Earns $2.7 Million NIH Grant to Alleviate Toxicities Associated With Immunotherapy","datePublished":"2025-07-09T19:28:58+00:00","dateModified":"2026-05-01T19:12:30+00:00","mainEntityOfPage":{"@id":"https:\/\/med.virginia.edu\/bims\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\/"},"wordCount":216,"image":{"@id":"https:\/\/med.virginia.edu\/bims\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\/#primaryimage"},"thumbnailUrl":"https:\/\/med.virginia.edu\/bims\/wp-content\/uploads\/sites\/390\/2025\/07\/Dudley_Andrew-1x1-1-300x300-1.webp","articleSection":["Research Highlights"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/med.virginia.edu\/bims\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\/","url":"https:\/\/med.virginia.edu\/bims\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\/","name":"Andrew Dudley, PhD, Earns $2.7 Million NIH Grant to Alleviate Toxicities Associated With Immunotherapy - Biomedical Sciences Graduate Program","isPartOf":{"@id":"https:\/\/med.virginia.edu\/bims\/#website"},"primaryImageOfPage":{"@id":"https:\/\/med.virginia.edu\/bims\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\/#primaryimage"},"image":{"@id":"https:\/\/med.virginia.edu\/bims\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\/#primaryimage"},"thumbnailUrl":"https:\/\/med.virginia.edu\/bims\/wp-content\/uploads\/sites\/390\/2025\/07\/Dudley_Andrew-1x1-1-300x300-1.webp","datePublished":"2025-07-09T19:28:58+00:00","dateModified":"2026-05-01T19:12:30+00:00","author":{"@id":"https:\/\/med.virginia.edu\/bims\/#\/schema\/person\/04dfd1e9dffba7133a63ffcb935dbad5"},"breadcrumb":{"@id":"https:\/\/med.virginia.edu\/bims\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/med.virginia.edu\/bims\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/med.virginia.edu\/bims\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\/#primaryimage","url":"https:\/\/med.virginia.edu\/bims\/wp-content\/uploads\/sites\/390\/2025\/07\/Dudley_Andrew-1x1-1-300x300-1.webp","contentUrl":"https:\/\/med.virginia.edu\/bims\/wp-content\/uploads\/sites\/390\/2025\/07\/Dudley_Andrew-1x1-1-300x300-1.webp","width":300,"height":300,"caption":"Andrew Dudley PhD"},{"@type":"BreadcrumbList","@id":"https:\/\/med.virginia.edu\/bims\/andrew-dudley-phd-earns-2-7-million-nih-grant-to-alleviate-toxicities-associated-with-immunotherapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/med.virginia.edu\/bims\/"},{"@type":"ListItem","position":2,"name":"Andrew Dudley, PhD, Earns $2.7 Million NIH Grant to Alleviate Toxicities Associated With Immunotherapy"}]},{"@type":"WebSite","@id":"https:\/\/med.virginia.edu\/bims\/#website","url":"https:\/\/med.virginia.edu\/bims\/","name":"Biomedical Sciences Graduate Program","description":"University of Virginia School of Medicine","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/med.virginia.edu\/bims\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/med.virginia.edu\/bims\/#\/schema\/person\/04dfd1e9dffba7133a63ffcb935dbad5","name":"amc3yu@virginia.edu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/14b7fd4ac1415b0f4430fd13352b7565baec1c8cde504b3154183d83d9c35a25?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/14b7fd4ac1415b0f4430fd13352b7565baec1c8cde504b3154183d83d9c35a25?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/14b7fd4ac1415b0f4430fd13352b7565baec1c8cde504b3154183d83d9c35a25?s=96&d=mm&r=g","caption":"amc3yu@virginia.edu"},"url":"https:\/\/med.virginia.edu\/bims\/author\/amc3yuvirginia-edu\/"}]}},"_links":{"self":[{"href":"https:\/\/med.virginia.edu\/bims\/wp-json\/wp\/v2\/posts\/4924","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/med.virginia.edu\/bims\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/med.virginia.edu\/bims\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/med.virginia.edu\/bims\/wp-json\/wp\/v2\/users\/2214"}],"replies":[{"embeddable":true,"href":"https:\/\/med.virginia.edu\/bims\/wp-json\/wp\/v2\/comments?post=4924"}],"version-history":[{"count":3,"href":"https:\/\/med.virginia.edu\/bims\/wp-json\/wp\/v2\/posts\/4924\/revisions"}],"predecessor-version":[{"id":4928,"href":"https:\/\/med.virginia.edu\/bims\/wp-json\/wp\/v2\/posts\/4924\/revisions\/4928"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/med.virginia.edu\/bims\/wp-json\/wp\/v2\/media\/4926"}],"wp:attachment":[{"href":"https:\/\/med.virginia.edu\/bims\/wp-json\/wp\/v2\/media?parent=4924"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/med.virginia.edu\/bims\/wp-json\/wp\/v2\/categories?post=4924"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/med.virginia.edu\/bims\/wp-json\/wp\/v2\/tags?post=4924"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}